1921
Live-attenuated dengue vaccine development
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

As part of a larger vaccine study, peripheral blood mononuclear cells (PBMC) were collected from volunteers for analysis of vaccine- induced T cell responses. The PBMC were re-stimulated with live dengue virus and assayed for T1 or T2 memory cell responses. Re-stimulated PBMC from the volunteers predominantly secreted interferon-γ. Little interleukin-4 (IL-4) or IL-10 secretion was detected, indicating a T1 type of T cell response. The interferon-γ response was primarily serotype-specific with some serotype cross-reactivity. T cell depletion studies showed that the interferon-γ was being secreted by CD4+ T lymphocytes and/or by cells other than CD8+ T lymphocytes that were being stimulated by the CD4+ T lymphocytes. CD3+ or CD8+ T cell depletion showed that granzyme B mRNA expression correlated with the presence of CD4+ T lymphocytes. However, depletion of CD4+ T cells after four days of stimulation indicated that the granzyme B mRNA was produced by cells in culture other than lymphocytes. In summary, an antigen-specific T1 type T cell response was seen as a response to vaccination using live attenuated dengue virus.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2003.69.39
2003-12-01
2017-11-22
Loading full text...

Full text loading...

/deliver/fulltext/14761645/69/6_suppl/0690039.html?itemId=/content/journals/10.4269/ajtmh.2003.69.39&mimeType=html&fmt=ahah

References

  1. Vaughn DW, Hoke CH Jr, Yoksan S, LaChance R, Innis BL, Rice RM, Bhamarapravati N, 1996. Testing of a dengue 2 live-attenuated vaccine (strain 16681 PDK 53) in ten American volunteers. Vaccine 14 : 329–336.
  2. Edelman R, Tacket CO, Wasserman SS, Vaughn DW, Eckels KH, Dubois DR, Summers PL, Hoke CH, 1994. A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans. J Infect Dis 170 : 1448–1455.
  3. Hoke CH Jr, Malinoski FJ, Eckels KH, Scott RM, Dubois DR, Summers PL, Simms T, Burrous J, Hasty SE, Bancroft WH, 1990. Preparation of an attenuated dengue 4 (341750 Carib) virus vaccine. II. Safety and immunogenicity in humans. Am J Trop Med Hyg 43 : 219–226.
  4. Eckels KH, Scott RM, Bancroft WH, Brown J, Dubois DR, Summers PL, Russell PK, Halstead SB, 1984. Selection of attenuated dengue 4 viruses by serial passage in primary kidney cells. V. Human response to immunization with a candidate vaccine prepared in fetal rhesus lung cells. Am J Trop Med Hyg 33 : 684–689.
  5. Mosmann TR, 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136 : 2348–2357.
  6. Peters M, 1996. Actions of cytokines on the immune response and viral interactions: an overview. Hepatology 23 : 909–916.
  7. Conrad DH, Ben-Sasson SZ, Le Gross G, Finkleman FD, Paul WE, 1990. Infection with Nipostrongylus braziliensis. J Exp Med 171 : 1497–1508.
  8. Pacsa AS, Agarwal R, Elbishbishi EA, Chaturvedi UC, Nagar R, Mustafa AS, 2000. Role of interleukin-12 in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol 28 : 151–155.
  9. Kurane I, Innis BL, Nimmannitya S, Nisalak A, Meager A, Janus J, Ennis FA, 1991. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J Clin Invest 88 : 1473–1480.
  10. Johnson AJ, Roehrig JT, 1999. New mouse model for dengue virus vaccine testing. J Virol 73 : 783–786.
  11. Kontny U, Kurane I, Ennis FA, 1988. Gamma interferon augments Fc gamma receptor-mediated dengue virus infection of human monocytic cells. J Virol 62 : 3928–3933.
  12. Sittisombut N, Maneekarn N, Kanjanahaluethai A, Kasinrerk W, Viputtikul K, Supawadee J, 1995. Lack of augmenting effect of interferon-gamma on dengue virus multiplication in human peripheral blood monocytes. J Med Virol 45 : 43–49.
  13. Kurane I, Brinton MA, Samson AL, Ennis FA, 1991. Dengue virus-specific, human CD4+ CD8- cytotoxic T-cell clones: multiple patterns of virus cross-reactivity recognized by NS3-specific T-cell clones. J Virol 65 : 1823–1828.
  14. Kurane I, Rothman AL, Livingston PG, Green S, Gagnon SJ, Janus J, Innis BL, Nimmannitya S, Nisalak A, Ennis FA, 1994. Immunopathologic mechanisms of dengue hemor-rhagic fever and dengue shock syndrome. Arch Virol (suppl) 9 : 59–64.
  15. Dharakul T, Kurane I, Bhamarapravati N, Yoksan S, Vaughn DW, Hoke CH, Ennis FA, 1994. Dengue virus-specific memory T cell responses in human volunteers receiving a live attenuated dengue virus type 2 candidate vaccine. J Infect Dis 170 : 27–33.
  16. Kurane I, Meager A, Ennis FA, 1989. Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity. J Exp Med 170 : 763–775.
  17. Kurane I, Innis BL, Hoke CH Jr, Eckels KH, Meager A, Janus J, Ennis FA, 1995. T cell activation in vivo by dengue virus infection. J Clin Lab Immunol 46 : 35–40.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2003.69.39
Loading
/content/journals/10.4269/ajtmh.2003.69.39
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error